In a study conducted by Aneta et al. presented a novel magneto-immunosensor that utilized electrochemical nanocomposites for the simultaneous quantification of three ovarian cancer biomarkers (human epididymis secretory protein 4 (HE4), AFP, and CA-125) [78]. Here, WFDC2 is linked to ovarian carcinoma.